BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8378093)

  • 21. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
    Whiteside ST; Epinat JC; Rice NR; Israël A
    EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of three splice variants and genomic organization of the mouse BMAL1 gene.
    Yu W; Ikeda M; Abe H; Honma S; Ebisawa T; Yamauchi T; Honma K; Nomura M
    Biochem Biophys Res Commun; 1999 Jul; 260(3):760-7. PubMed ID: 10403839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma.
    Galiègue-Zouitina S; Quief S; Hildebrand MP; Denis C; Detourmignies L; Laï JL; Kerckaert JP
    Genes Chromosomes Cancer; 1999 Oct; 26(2):97-105. PubMed ID: 10469447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of negative regulatory regions within the first exon and intron of the BCL6 gene.
    Kikuchi M; Miki T; Kumagai T; Fukuda T; Kamiyama R; Miyasaka N; Hirosawa S
    Oncogene; 2000 Oct; 19(42):4941-5. PubMed ID: 11039912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.
    Yoshida S; Kaneita Y; Aoki Y; Seto M; Mori S; Moriyama M
    Oncogene; 1999 Dec; 18(56):7994-9. PubMed ID: 10637510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
    Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
    Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y; Hostager BS; Bishop GA
    J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4.
    Kawamata N; Sakajiri S; Sugimoto KJ; Isobe Y; Kobayashi H; Oshimi K
    Oncogene; 2002 Jul; 21(32):4983-91. PubMed ID: 12118377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic organization of the human beta-catenin gene (CTNNB1).
    Nollet F; Berx G; Molemans F; van Roy F
    Genomics; 1996 Mar; 32(3):413-24. PubMed ID: 8838805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The generation of nfkb2 p52: mechanism and efficiency.
    Heusch M; Lin L; Geleziunas R; Greene WC
    Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
    Goto M; Yamada K; Katayama K; Tanaka I
    Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic organization of the human ATP1AL1 gene encoding a ouabain-sensitive H,K-ATPase.
    Sverdlov VE; Kostina MB; Modyanov NN
    Genomics; 1996 Mar; 32(3):317-27. PubMed ID: 8838794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural features of hematopoiesis-specific RhoH/ARHH gene: high diversity of 5'-UTR in different hematopoietic lineages suggests a complex post-transcriptional regulation.
    Lahousse S; Smorowski AL; Denis C; Lantoine D; Kerckaert JP; Galiègue-Zouitina S
    Gene; 2004 Dec; 343(1):55-68. PubMed ID: 15563831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
    Najfeld V; Cozza A; Berkofsy-Fessler W; Prchal J; Scalise A
    Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Mol Cell Biol; 1995 Sep; 15(9):5180-7. PubMed ID: 7651435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic organization and chromosomal mapping of mouse nuclear factor kappa B 2 (NFKB2).
    Paxian S; Liptay S; Adler G; Hameister H; Schmid RM
    Immunogenetics; 1999 Aug; 49(9):743-50. PubMed ID: 10398801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.